Immediate Impact
62 standout
Citing Papers
Psychotropic Drug–Related Weight Gain and Its Treatment
2024 Standout
Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial
2023 Standout
Works of Michael Beary being referenced
A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications
2012
Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Beary | 124 | 39 | 30 | 131 | 9 | 310 | |
| Andrew Keen | 126 | 62 | 13 | 96 | 9 | 330 | |
| Ane Storch Jakobsen | 69 | 109 | 25 | 204 | 8 | 316 | |
| Lene Nyboe | 85 | 131 | 20 | 163 | 16 | 316 | |
| Jatinder Bains | 74 | 40 | 9 | 165 | 9 | 369 | |
| Anne Clair | 46 | 33 | 17 | 157 | 11 | 361 | |
| Jori Perälä | 87 | 27 | 12 | 117 | 10 | 291 | |
| Harry Boothby | 129 | 73 | 52 | 182 | 11 | 350 | |
| Daniel B. Schuster | 91 | 18 | 11 | 130 | 13 | 305 | |
| Ishwar V. Basavaraddi | 170 | 66 | 9 | 86 | 17 | 313 | |
| J. Crawford Little | 62 | 19 | 19 | 80 | 14 | 295 |
All Works
Loading papers...